Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL4882298

CC[n+]1c(C)ccc2cc(N(C)C)ccc21.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 3/20 0.40
NR2F2 P24468 2/20 0.40
KDM4E B2RXH2 5/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
PPARG P37231 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CRHR1 P34998 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4879137 0.84 KDM4E (0.39) NSD2KDM4ELMNAALDH1A1GAA
Trifluoromethanesulfonic Acid SCHEMBL4878037 0.84 NSD2 (0.44) NSD2NR2F2LMNAMEN1POLB
Trifluoromethanesulfonic Acid SCHEMBL4883845 0.82 KDM4E (0.42) KDM4ELMNAALDH1A1GAAHPGD
Trifluoromethanesulfonic Acid SCHEMBL4888872 0.75 AR (0.63) NSD2NR2F2KDM4ELMNAALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL4888866 0.75 AR (0.63) NSD2NR2F2KDM4ELMNAALDH1A1
SCHEMBL4886222 0.72 SYNJ2 (0.40) NSD2NR2F2KDM4ELMNAALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL4886009 0.71 ACHE (0.58) NSD2NR2F2KDM4ELMNAALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL4886012 0.71 ACHE (0.58) NSD2NR2F2KDM4ELMNAALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL23356585 0.68 NSD2 (0.43) NSD2NR2F2CFTRGOPCHSP90AA1
Trifluoromethanesulfonic Acid SCHEMBL30032968 0.68 ACHE (0.35) NSD2NR2F2KDM4ECFTRGOPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080281105-A1 Novel Quinolinium Salts and Derivatives IMMUSOL INCORPORATED (US) 2008-11-13 US disclosed
EP-1841428-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES Immusol Incorporated (US) 2007-10-10 EP disclosed
WO-2006078754-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES IMMUSOL INCORPORATED (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281105-A1 Novel Quinolinium Salts and Derivatives NQO2, MCL1, KRAS NSD2 692/4885NR2F2 3105/4885KDM4E 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.